About Burnet Pharmaceuticals Pvt Ltd
Data last updated:
Burnet Pharmaceuticals Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U34232WB1982PTC035307. Its GSTIN is 19AABCB0419J1ZV (West Bengal). The company holds 7 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.52 Cr. It is led by directors including Ram Rekha Tewari (Managing Director) and Shiv Sagar Tewari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 28/5 C.N. Roy Road, Kolkata, West Bengal, India – 700039.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.28 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹8.35 Lakh (net margin 0.6%) and EBITDA of ₹71.06 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 1% over five years.
The company has about 131 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹17.75 Cr on record. Court records list 14 cases involving the company, including 9 filed by the company and 5 filed against it; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website burnetpharma.org.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address28/5 C.N. Roy Road, Kolkata, West Bengal, India – 700039
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Burnet Pharmaceuticals Pvt Ltd
The main business activity of Burnet Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Burnet Pharmaceuticals Pvt Ltd FY 2024 filings available
Burnet Pharmaceuticals Pvt Ltd reported revenue of ₹13.28 Cr (up 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Burnet Pharmaceuticals Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 26% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Burnet Pharmaceuticals Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71.06 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Burnet Pharmaceuticals Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Burnet Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xemex Pharmaceuticals Private Limited | ₹13.35 Cr (FY 2024) | •••• | •••• | 90.0% | •••• | Chennai, Tamil Nadu, India |
| Navin Saxena Research and Technology Private Limited | ₹13.34 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Pharmacare Aura Private Limited | ₹13.33 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | Paonta Sahib, Himachal Pradesh, India |
| Dymes Pharmachem Limited | ₹13.33 Cr (FY 2015) | •••• | •••• | -17.0% | •••• | Hyderabad, Telangana, India |
| Bryogen Pharmaceuticals Private Limited | ₹13.32 Cr (FY 2025) | •••• | •••• | 108.0% | •••• | Gurgaon, Haryana, India |
| Burnet Pharmaceuticals Pvt Ltd this company | ₹13.28 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Kolkata, West Bengal, India |
| Jocund India Limited | ₹13.26 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Neiss Labs Limited | ₹13.26 Cr (FY 2024) | •••• | •••• | 54.0% | •••• | Varanasi, Uttar Pradesh, India |
| Genees Pharmaceutical Private Limited | ₹13.26 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Pune, Maharashtra, India |
| Zinnia Life Sciences Private Limited | ₹13.25 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Coimbatore, Tamil Nadu, India |
| Iaso Pharmaceuticals Private Limited | ₹13.2 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Burnet Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals Pvt Ltd is audited by MADHU SHARMA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MADHU SHARMA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Rekha Tewari Also directs: Burnet Medicare Private Limited | Managing Director | 30 Sep 1982 | 44 Years 0 Months | Current |
| Shiv Sagar Tewari Also directs: Burnet Medicare Private Limited | Director | 01 Jan 1983 | 43 Years 9 Months | Current |
| Om Prakash Singh | Additional Director | 01 Oct 2024 | 2 Years 0 Months | Current |
Ownership and Shareholding of Burnet Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Burnet Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2024 | Others | ₹5.76 Cr | Open |
| 28 Jul 2023 | Axis Bank Limited | ₹4.35 Cr | Open |
| 28 Dec 2021 | Axis Bank Limited | ₹30 Lakh | Open |
| 20 Feb 2021 | Axis Bank Limited | ₹32 Lakh | Open |
| 18 Feb 2004 | United Bank of India | ₹3.48 Cr | Open |
Total charge records: 7 View all charges
Legal Cases of Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals Pvt Ltd has 14 court cases on record: 9 filed by Burnet Pharmaceuticals, 5 filed against it. 4 cases are pending and 10 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 4 | 0 |
| District courts | 7 | 1 | 4 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed by the company against Sanjeevani Bio-Tech Private Limited | Pending |
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Sanjeevani Bio-Tech Private Limited | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed by the company against New Akash Enterprises and 1 other | Pending |
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed by the company against an individual | Pending |
| District court, North Twenty Four Parganas, West Bengal | Civil suit | Filed by the company against an individual | Pending |
Full case history
All 14 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals Pvt Ltd has a workforce of 131 employees as of Sep 16, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals Pvt Ltd has 9 board changes on record since 1982: 6 appointments and 3 cessations. The latest: Om Prakash Singh was appointed as Additional Director on 01 Oct 2024.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Burnet Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Burnet Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Burnet Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals has 7 GST registrations: 4 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCB0419J1ZV | West Bengal | Active | 01 Jul 2017 |
| 09AABCB0419J1ZW | Uttar Pradesh | Active | 01 Jul 2017 |
| 27AABCB0419J1ZY | Maharashtra | Active | 24 Dec 2024 |
| 27AABCB0419J2ZX | Maharashtra | Active | 01 May 2025 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Burnet Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Burnet Pharmaceuticals Pvt Ltd
Burnet Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 1982 (44+ years old) and is registered under CIN U34232WB1982PTC035307.
Burnet Pharmaceuticals reported revenue of ₹13.28 Cr for FY 2024 (up 26% YoY).
Burnet Pharmaceuticals has 3 current directors:
- Ram Rekha Tewari - Managing Director
- Shiv Sagar Tewari - Director
- Om Prakash Singh - Additional Director
Burnet Pharmaceuticals reported a net profit of ₹8.35 Lakh (net margin 0.6%) and EBITDA of ₹71.06 Lakh (EBITDA margin 5.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Burnet Pharmaceuticals is 5% over three years and 1% over five years. In the latest year (FY 2024) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Burnet Pharmaceuticals is 19AABCB0419J1ZV, registered in West Bengal. The company has 7 GST registrations in all, of which 4 are active and 3 are cancelled or inactive. Other active GSTINs include 09AABCB0419J1ZW (Uttar Pradesh), 27AABCB0419J1ZY (Maharashtra), 27AABCB0419J2ZX (Maharashtra).
The CIN (Corporate Identification Number) of Burnet Pharmaceuticals is U34232WB1982PTC035307. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Burnet Pharmaceuticals has 14 court cases on record: 9 filed by the company and 5 filed against it. 4 are pending. Most are in the high courts.
Burnet Pharmaceuticals was incorporated on 30 September 1982, making it 44+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Burnet Pharmaceuticals by revenue are Xemex Pharmaceuticals Private Limited, Navin Saxena Research and Technology Private Limited, Pharmacare Aura Private Limited, Dymes Pharmachem Limited, Bryogen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Om Prakash Singh was appointed as Additional Director on 01 Oct 2024. Lalita Tewari ceased to be Director on 01 Jun 2018. Satyawati Tewari ceased to be Director on 01 Jun 2018. Burnet Pharmaceuticals has 9 board changes on record in total.